| Q33687191 | 5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic |
| Q37130522 | 5-HTTLPR status moderates the effect of early adolescent substance use on risky sexual behavior |
| Q88289189 | A Critical Review of Methods and Results in the Search for Genetic Contributors to Alcohol Sensitivity |
| Q36890264 | A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence |
| Q35088135 | A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype |
| Q50104709 | A nonhuman primate model of type II excessive alcohol consumption? Part 1. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations and diminished social competence correlate with excessive alcohol consumption |
| Q34646715 | A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity |
| Q51408749 | A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. |
| Q73508413 | A tryptophan-free diet markedly reduces frontocortical 5-HT release, but fails to modify ethanol preference in alcohol-preferring (sP) and non-preferring (sNP) rats |
| Q37288940 | Activation of liver tryptophan pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects |
| Q71538989 | Acute effect of altered tryptophan levels and alcohol on aggression in normal human males |
| Q44318861 | Acute effect of simultaneous administration of tryptophan and ethanol on serotonin metabolites in the locus coeruleus in rats |
| Q53630812 | Adaptive and maladaptive impulsivity, platelet monoamine oxidase (MAO) activity and risk-admitting in different types of risky drivers. |
| Q34011095 | Adolescent Suicidal Behavior and Substance Use: Developmental Mechanisms |
| Q39372432 | Adolescent intermittent ethanol reduces serotonin expression in the adult raphe nucleus and upregulates innate immune expression that is prevented by exercise |
| Q57159289 | Alcohol consumption behaviors and neurocognitive dysfunction and emotional distress in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study |
| Q33934634 | Alcoholics have more tryptophan hydroxylase 2 mRNA and protein in the dorsal and median raphe nuclei |
| Q33921626 | Alcoholism: the role of different motivational systems |
| Q44594245 | Alleles of a functional serotonin transporter promoter polymorphism are associated with major depression in alcoholics |
| Q45917874 | An investigation of associations between alcohol use disorder and polymorphisms on ALDH2, BDNF, 5-HTTLPR, and MTHFR genes in older Korean men. |
| Q43913122 | An investigation of the role of 5-HT(2C) receptors in modifying ethanol self-administration behaviour |
| Q44016875 | Anabolic androgenic steroid affects competitive behaviour, behavioural response to ethanol and brain serotonin levels |
| Q53267909 | Association between HTR7 genetic polymorphisms and alcohol dependence, using the alcohol use disorders identification test (AUDIT). |
| Q35204500 | Association of polymorphisms in HTR2A, HTR1A and TPH2 genes with suicide attempts in alcohol dependence: a preliminary report |
| Q44156387 | Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene |
| Q40697556 | Association study of serotonin transporter gene regulatory region polymorphism and alcoholism |
| Q39855532 | Availability of the serotonin transporter in patients with alcohol dependence |
| Q44867644 | Biological and behavioral markers of alcohol sensitivity |
| Q52296754 | Biological phenotypes associated with individuals at high risk for developing alcohol-related disorders: Part 1. |
| Q37461891 | Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors |
| Q30435247 | Can serotonin transporter genotype predict craving in alcoholism? |
| Q30440570 | Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? |
| Q34566111 | Cellular and mitochondrial effects of alcohol consumption |
| Q48903714 | Central serotonergic lesions increase voluntary alcohol consumption in Sprague Dawley rats: moderation by long-term ethanol administration |
| Q50961770 | Changes in the methylation status of DAT, SERT, and MeCP2 gene promoters in the blood cell in families exposed to alcohol during the periconceptional period. |
| Q41149014 | Characteristics and putative mechanisms in boys at risk for drug abuse and aggression. |
| Q30437148 | Characterization of a functional polymorphism in the 3' UTR of SLC6A4 and its association with drinking intensity |
| Q51820092 | Characterization of functional polymorphisms and glucocorticoid-responsive elements in the promoter of TDO2, a candidate gene for ethanol-induced behavioural disorders. |
| Q43972777 | Congenic mapping of alcohol and pentobarbital withdrawal liability loci to a <1 centimorgan interval of murine chromosome 4: identification of Mpdz as a candidate gene. |
| Q37418720 | Congenital brain serotonin deficiency leads to reduced ethanol sensitivity and increased ethanol consumption in mice |
| Q30491755 | Corticotropin-releasing factor 1 and 2 receptors in the dorsal raphé differentially affect serotonin release in the nucleus accumbens |
| Q37607547 | Corticotropin-releasing factor in the dorsal raphe nucleus: Linking stress coping and addiction |
| Q43054732 | Decreased cerebral cortex and liver 5-HT2A receptor gene expression and enhanced ALDH activity in ethanol-treated rats and hepatocyte cultures |
| Q44940745 | Decreased histamine-stimulated phosphoinositide hydrolysis in the cerebral cortex of a rat line selectively bred for high alcohol preference |
| Q51072341 | Depressive relapse following acute tryptophan depletion in patients with major depressive disorder. |
| Q30434334 | Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter. |
| Q33921555 | Drugs and aggression: correlations, crime and human manipulative studies and some proposed mechanisms |
| Q41881779 | Effect of Withinia Somnifera and Shilajit on Alcohol Addiction in Mice |
| Q34268902 | Effect of fluoxetine and bromocriptine on craving occurring during withdrawal from alcohol. |
| Q44407227 | Effect of one-week ethanol treatment on monoamine levels and dopaminergic receptors in rat striatum |
| Q43645155 | Effects of 5-HT1A and 5-HT2 receptor agonists on the behavioral and neurochemical consequences of repeated nicotine treatment |
| Q48251120 | Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers |
| Q48680074 | Effects of acute, chronic ethanol and withdrawal on dorsal raphe neurons: electrophysiological studies |
| Q40844399 | Effects of moderate alcohol consumption on the central nervous system |
| Q44588970 | Effects of rapid tryptophan depletion on mood and urge to drink in patients with co-morbid major depression and alcohol dependence |
| Q52167934 | Effects of serotonergic manipulations on the behavioral sensitization and disinhibition associated with repeated amphetamine treatment. |
| Q40742099 | Efficacy of dexfenfluramine in the treatment of alcohol dependence |
| Q78390441 | Electrical stimulation of nucleus raphe dorsalis changes morphine self-administration and withdrawal symptoms in rats |
| Q48937190 | Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors |
| Q59078063 | Elevated tryptophan levels in post-withdrawal alcoholics |
| Q73574709 | Ethanol and trichloroethanol alter gating of 5-HT3 receptor-channels in NCB-20 neuroblastoma cells |
| Q36269244 | Ethanol consumption in the Sprague-Dawley rat increases sensitivity of the dorsal raphe nucleus to 5,7-dihydroxytryptamine |
| Q38664894 | Exercise training - A beneficial intervention in the treatment of alcohol use disorders? |
| Q37642454 | Extrasynaptic glycine receptors of rodent dorsal raphe serotonergic neurons: a sensitive target for ethanol |
| Q43721043 | Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype |
| Q46961734 | Genetic and other contributions to alcohol intake in rhesus macaques (Macaca mulatta). |
| Q44327678 | Genetics of alcoholism using intermediate phenotypes |
| Q33952958 | Genotype effects on neurodegeneration and neuroadaptation in monoaminergic neurotransmitter systems |
| Q44219393 | Hormone responses to citalopram in abstinent alcohol dependent subjects |
| Q34611934 | Impact of tryptophan metabolism on the vulnerability to alcohol-related blackouts and violent impulsive behaviours |
| Q37135977 | In vitro and in vivo models of acute alcohol exposure |
| Q92699472 | Integrating Preclinical and Clinical Models of Negative Urgency |
| Q34558819 | Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake |
| Q43842930 | Is long-term heavy alcohol consumption toxic for brain serotonergic neurons? Relationship between years of excessive alcohol consumption and serotonergic neurotransmission |
| Q34547375 | Mirtazapine improves alcohol detoxification. |
| Q36589468 | Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment |
| Q38145450 | Molecular and genetic determinants of alcohol dependence |
| Q48695080 | Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice |
| Q48566219 | Nefazodone attenuates the behavioral and neurochemical effects of ethanol |
| Q49891916 | Negative Urgency Mediates the Relation between Genetically-Influenced Serotonin Functioning and Alcohol Problems |
| Q35164057 | Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction |
| Q34002764 | Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol |
| Q52277471 | Oral ethanol self-administration in rhesus monkeys: behavioral and neurochemical correlates. |
| Q46931697 | Personality profile in type I alcoholism: long duration of alcohol intake and low serotonergic activity are predictive factors of anxiety proneness |
| Q38027330 | Personalized treatment of alcohol dependence |
| Q34707077 | Pharmaceutical agents known to produce disulfiram-like reaction: effects on hepatic ethanol metabolism and brain monoamines. |
| Q37708082 | Pharmacological approaches to reducing craving in patients with alcohol use disorders |
| Q24813717 | Pharmacological challenge with a serotonin 1D agonist in alcohol dependence |
| Q77468736 | Pharmacological treatment of alcoholism |
| Q36461774 | Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention. |
| Q30438482 | Prediction of serotonergic treatment efficacy using age of onset and Type A/B typologies of alcoholism |
| Q35792549 | Regulation of 5-HT2A/C receptors and DOI-induced behaviors by protein kinase Cgamma |
| Q38926517 | Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities |
| Q43647888 | Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram |
| Q34101553 | Relationship between the serotonin transporter polymorphism and obsessive-compulsive alcohol craving in alcohol-dependent adults: a pilot study |
| Q87297772 | Retraction: Biochemical predictors of delirium tremens in patients in alcohol withdrawal |
| Q48158881 | Risky alcohol use in adolescence: the role of genetics (DRD2, SLC6A4) and coping motives |
| Q48770411 | Ritanserin in relapse prevention in abstinent alcoholics: results from a placebo-controlled double-blind international multicenter trial. Ritanserin in Alcoholism Work Group |
| Q36481024 | Role of 5-hydroxytryptamine 1B (5-HT1B) receptors in the regulation of ethanol intake in rodents |
| Q36429331 | Role of the serotonergic system in alcohol dependence: from animal models to clinics |
| Q30435306 | Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment |
| Q79656767 | SNP- and haplotype analysis of the tryptophan hydroxylase 2 gene in alcohol-dependent patients and alcohol-related suicide |
| Q40820686 | Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study |
| Q48735907 | Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974. |
| Q34068521 | Serotonergic agents and alcoholism treatment: rebirth of the subtype concept--an hypothesis |
| Q48581255 | Serotonergic dysfunction in addiction: effects of alcohol, cigarette smoking and heroin on platelet 5-HT content |
| Q34236249 | Serotonergic dysfunction, negative mood states, and response to alcohol |
| Q36679249 | Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. |
| Q38769466 | Serotonin functioning and adolescents' alcohol use: A genetically informed study examining mechanisms of risk |
| Q60044809 | Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity |
| Q44334408 | Serotonin transporter availability correlates with alcohol intake in non-human primates |
| Q74227440 | Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior |
| Q74297253 | Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity |
| Q47971458 | Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder |
| Q43249742 | Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics |
| Q36037118 | Serotonin's role in alcohol's effects on the brain. |
| Q48925780 | Serotonin2C receptors and serotonin2C receptor-mediated phosphoinositide hydrolysis in the brain of alcohol-preferring and alcohol-nonpreferring rats |
| Q46381531 | Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder |
| Q34320975 | Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. |
| Q43813771 | Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol-induced conditioned-place preference and voluntary alcohol consumption |
| Q34801585 | Structural and functional modifications in glutamateric synapses following prolonged ethanol exposure |
| Q36928596 | The 5-HTTLPR polymorphism moderates the effect of stressful life events on drinking behavior in college students of African descent |
| Q61810573 | The association between gene rs13212041 polymorphism and onset of alcohol abuse |
| Q44451570 | The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study |
| Q36037104 | The neurobiology of addiction: an overview. |
| Q30886912 | The relationship of alcohol use disorders and depressive symptoms to tryptophan metabolism: cross-sectional data from a Nepalese alcohol treatment sample |
| Q42669539 | Tianeptine and alcohol dependence |
| Q44579531 | Tobacco use is associated with reduced central serotonergic neurotransmission in type 1 alcohol-dependent individuals |
| Q37226468 | Tryptophan hydroxylase 2 gene and alcohol use among college students |
| Q38747900 | Tryptophan in alcoholism treatment I: kynurenine metabolites inhibit the rat liver mitochondrial low Km aldehyde dehydrogenase activity, elevate blood acetaldehyde concentration and induce aversion to alcohol |
| Q41199444 | Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence |
| Q28259406 | What are the costs of marital conflict and dissolution to children's physical health? |